Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
HEMOSENSE INC (HEM) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/13/2010 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
12/13/2010 EFFECT Form EFFECT - Notice of Effectiveness
12/08/2010 S-4/A Form S-4 - Registration of securities, business combinations [amend]
10/06/2010 D Form D - Notice of Exempt Offering of Securities
05/25/2010 8-K Other Events, Financial Statements and Exhibits
Docs: "Inverness Medical Innovations, Inc. Extends Exchange Offer for 7.875% Senior Notes due 2016"
04/23/2010 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]
04/22/2010 EFFECT Form EFFECT -
02/12/2010 S-4 Form S-4 - Registration of securities, business combinations
08/06/2009 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]
05/12/2009 8-A12B Form 8-A12B -- Registration of securities [Section 12(b)]
05/08/2009 424B5 Form 424B5 -- Prospectus [Rule 424(b)(5)]
05/04/2009 424B5 Form 424B5 -- Prospectus [Rule 424(b)(5)]
04/10/2009 S-3ASR Form S-3ASR -- Automatic shelf registration statement of securities of well-known seasoned issuers
10/22/2007 8-K Quarterly results
10/09/2007 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
10/02/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
09/10/2007 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
09/10/2007 SC 13G FMR CORP reports a 11.2% stake in Hemosense Inc
08/28/2007 SC 13G/A Visium Balanced Fund LP reports a 7% stake in HEMOSENSE, INC.
08/13/2007 10-Q Quarterly Report for the period ended June 30, 2007
08/08/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/07/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/07/2007 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
08/07/2007 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "HEMOSENSE FISCAL THIRD QUARTER REVENUE INCREASES 101%"
08/07/2007 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits
Docs: "Agreement and Plan of Reorganization, by and among Inverness Medical Innovations, Inc., Spartan Merger Sub, Inc. and HemoSense, Inc",
"JOINT PRESS RELEASE DATED AUGUST 6, 2007"
07/17/2007 SC 13G/A Visium Balanced Fund LP reports a 8.6% stake in HEMOSENSE, INC.
05/11/2007 10-Q Quarterly Report for the period ended March 31, 2007
05/01/2007 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits
Docs: "Release of HemoSense, Inc."
03/09/2007 424B3 Form 424B3 -- Prospectus [Rule 424(b)(3)]
02/21/2007 8-K Other Events
02/13/2007 10-Q Quarterly Report for the period ended December 31, 2006
02/13/2007 SC 13G/A Visium Balanced Fund LP reports a 4.8% stake in HEMOSENSE, INC.
02/08/2007 SC 13G/A VANGUARD V L P reports a 5.3% stake in HemoSense, Inc.
02/08/2007 SC 13G/A BALYASNY ASSET MANAGEMENT LLC reports a 3.6% stake in HEMOSENSE, INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy